Respiratory
Point-of-care rapid testing for respiratory. OEM/ODM manufacturer.
Overview
COVID-19, influenza and RSV are the major seasonal respiratory viruses. Rapid antigen tests support syndromic diagnosis and triage.
Diagnostic Markers & Methods
Antigen tests (SARS-CoV-2, Influenza A/B, RSV) · multiplex combo devices · RT-PCR for confirmation.
Testing Window
Antigen best in the early symptomatic phase (first few days of symptoms).
Interpretation
Antigen tests are fast but less sensitive than molecular; a negative result during high prevalence does not exclude infection.
Confirmatory Testing
RT-PCR for respiratory viruses.
The Author's Take
Position: Sell the multiplex COVID/Flu/RSV combo, not single-target antigen tests — winter syndromic demand makes the combo the higher-margin, higher-utility SKU.
- Three viruses present identically; a combo resolves the differential in one test.
- Antigen tests are fast but less sensitive — set buyer expectations and offer PCR confirmation.
- Seasonal demand means inventory planning, not just product choice.
This is the buyer-advisor view of the technical team — editorial guidance, not a substitute for product IFU or local regulatory requirements.
Frequently Asked Questions
How accurate are rapid flu/COVID/RSV antigen tests?
Antigen tests are fast but less sensitive than molecular (PCR). A negative result during high prevalence does not exclude infection — confirm clinically or by PCR.
When should I use a multiplex respiratory test?
During respiratory season, when COVID, flu and RSV circulate together and symptoms overlap — a combo resolves the differential in one test.
Do rapid antigen tests detect asymptomatic infection?
Sensitivity is lower in asymptomatic or low-viral-load cases; antigen tests are most reliable in the early symptomatic phase.
Products (4)
Need a full Respiratory testing panel? Request datasheets, IFU and OEM/ODM options.